[Sulodexide in the prevention of post-mastectomy lymphedema].
Post-mastectomy lymphedema of the upper limb, that can be noticed by 10 to 20 percent of patients with breast cancer, is usually related to some risk factors: use of radiotherapy on the axilla, obesity, venous outflow obstruction, delayed wound healing or infection. The most important contributing factor to postsurgical edema is the development of lymphangitis in the upper limb. Although literature contains numerous accounts on the use of pharmacological agents for the treatment of postmastectomy lymphedema, the results are not satisfactory in term of clinical response and side effects. In the present study we investigate tolerability and feasibility of the use of suledexide in patients, submitted to mastectomy for breast cancer, with an initial lymphedema of the limb omolateral to surgery or other risk factors for the development of a clinical remarkable lymphedema. Our results show that sulodexide is a very satisfactory therapy in term of lack of side effects and good compliance.
Dini
D
D
Servizio di Rieducazione Funzionale, Istituto Nazionale per la Ricerca sul Cancro, Genova.
Gozza
A
A
Silvestro
S
S
Cavallari
M
M
Forno
G
G
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001132:Arm; D005260:Female; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D006801:Humans; D008209:Lymphedema / Q000209:etiology / Q000517:prevention & control*; D008408:Mastectomy / Q000009:adverse effects*; D008875:Middle Aged; D012307:Risk Factors
D006025:Glycosaminoglycans; C007858:glucuronyl glucosamine glycan sulfate
Il sulodexide nella prevenzione del linfedema post-mastectomia.